The Neuradiant 1070 represents the next generation photobiomodulation technology by being the first of its kind to deliver 1070 nanometre infrared light therapy to the brain in combination with the 4-quadrant control that enables clinicians to control the pulse in certain quadrants of the brain.br br You can read the results of a clinical trial showing that 1070 nanometre light therapy was successful in improving cognition in patients with dementia here: br You can find the study showing how the Neuradiant 1070 improved long COVID brain fog here: br Read independent reviews from people who have used the Neuradiant 1070 photobiomodulation helmet:br br br For a five per cent discount off the Neuradiant 1070 photobiomodulation helmet retail price please use this link: br Did you know Neuronic devotes 100 per cent of profits to advance the science and development of photobiomodulation through an ongoing program of basic science and applied clinical trials.